Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History $125.69 +0.27 (+0.22%) Closing price 06/30/2025 04:00 PM EasternExtended Trading$123.22 -2.47 (-1.97%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Neurocrine Biosciences Stock Price Performance The Neurocrine Biosciences (NBIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.29%, with a year-to-date return of -7.92%. In the past month, the stock has increased 2.43%, reflecting recent market activity. As of the latest close, Neurocrine Biosciences traded at $125.69 with a market cap of $12.44 billion and volume of 679,416 shares. Five years ago, the stock traded at $125.84, representing a 0.12% decrease over that period. At the time, it had a market cap of $11.65 billion and a volume of 1.18 million shares. Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.80%1 Month Performance+2.43%3 Month Performance+17.47%Year-To-Date Performance-7.92%1 Year Performance-10.29%5 Year Performance-0.12% NBIX Stock Chart for Tuesday, July, 1, 2025 NBIX Chart by TradingView Neurocrine Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$125.42$125.69+0.22%$127.36$125.42679,416 shs$12.44 billion06/27/2025$126.71$125.42-1.02%$127.26$125.021.26 million shs$12.41 billion06/26/2025$127.78$126.71-0.84%$128.66$126.20476,363 shs$12.54 billion06/25/2025$128.18$127.78-0.31%$128.61$126.61576,123 shs$12.65 billion06/24/2025$125.80$128.18+1.89%$128.50$123.04803,243 shs$12.69 billion06/23/2025$126.55$125.80-0.59%$127.99$125.061.06 million shs$12.45 billion06/20/2025$127.31$126.55-0.60%$128.38$125.531.58 million shs$12.52 billion06/19/2025$127.31$127.31$127.85$124.86957,258 shs$12.60 billion06/18/2025$124.88$127.31+1.95%$127.85$124.86957,258 shs$12.60 billion06/17/2025$125.00$124.88-0.10%$125.39$123.38807,029 shs$12.36 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$124.39$125.00+0.49%$126.00$123.12677,426 shs$12.37 billion06/13/2025$125.01$124.39-0.50%$125.54$122.66775,176 shs$12.31 billion06/12/2025$124.17$125.01+0.68%$125.91$123.69596,493 shs$12.37 billion06/11/2025$124.77$124.17-0.48%$125.51$123.97916,917 shs$12.29 billion06/10/2025$125.73$124.77-0.76%$127.51$124.39703,232 shs$12.35 billion06/09/2025$125.39$125.73+0.27%$126.89$123.97642,378 shs$12.44 billion06/06/2025$124.61$125.39+0.63%$126.81$124.08860,428 shs$12.41 billion06/05/2025$124.52$124.61+0.07%$125.24$123.33742,957 shs$12.33 billion06/04/2025$125.00$124.52-0.38%$125.99$124.29833,464 shs$12.32 billion06/03/2025$124.56$125.00+0.35%$126.33$123.411.29 million shs$12.37 billion06/02/2025$122.71$124.56+1.51%$124.89$121.831.31 million shs$12.33 billion05/30/2025$123.66$122.71-0.77%$123.93$121.421.83 million shs$12.14 billion Related Companies Alnylam Pharmaceuticals Stock Chart Biogen Stock Chart Incyte Stock Chart United Therapeutics Stock Chart Exelixis Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Repligen Stock Chart Halozyme Therapeutics Stock Chart Madrigal Pharmaceuticals Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
